Skip to main content
×
Home
    • Aa
    • Aa
  • Get access
    Check if you have access via personal or institutional login
  • Cited by 6
  • Cited by
    This article has been cited by the following publications. This list is generated based on data provided by CrossRef.

    Furman, David 2015. Sexual dimorphism in immunity: improving our understanding of vaccine immune responses in men. Expert Review of Vaccines, Vol. 14, Issue. 3, p. 461.


    Klein, Sabra L. 2012. Sex influences immune responses to viruses, and efficacy of prophylaxis and treatments for viral diseases. BioEssays, Vol. 34, Issue. 12, p. 1050.


    De Conto, F. Medici, M. C. Ferraglia, F. Pinardi, F. Fazzi, A. Arcangeletti, M. C. Chezzi, C. and Calderaro, A. 2016. Temporal dynamics of hepatitis C genotypes in a five-year hospital-based surveillance in Northern Italy. Archives of Virology, Vol. 161, Issue. 10, p. 2727.


    Uhanova, Julia Tate, Robert B Tataryn, Douglas J and Minuk, Gerald Y 2012. A population-based study of the epidemiology of hepatitis C in a North American population. Journal of Hepatology, Vol. 57, Issue. 4, p. 736.


    Head, M. G. Fitchett, J. R. Cooke, G. S. Foster, G. R. and Atun, R. 2015. Systematic analysis of funding awarded for viral hepatitis-related research to institutions in the United Kingdom, 1997-2010. Journal of Viral Hepatitis, Vol. 22, Issue. 3, p. 230.


    Cornberg, Markus Razavi, Homie A. Alberti, Alfredo Bernasconi, Enos Buti, Maria Cooper, Curtis Dalgard, Olav Dillion, John F. Flisiak, Robert Forns, Xavier Frankova, Sona Goldis, Adrian Goulis, Ioannis Halota, Waldemar Hunyady, Bela Lagging, Martin Largen, Angela Makara, Michael Manolakopoulos, Spilios Marcellin, Patrick Marinho, Rui T. Pol, Stanislas Poynard, Thierry Puoti, Massimo Sagalova, Olga Sibbel, Scott Simon, Krzysztof Wallace, Carolyn Young, Kendra Yurdaydin, Cihan Zuckerman, Eli Negro, Francesco and Zeuzem, Stefan 2011. A systematic review of hepatitis C virus epidemiology in Europe, Canada and Israel. Liver International, Vol. 31, p. 30.


    ×

Estimating hepatitis C infection acquired in England, 1986–2000

  • M. A. BALOGUN (a1), A. J. VYSE (a1), L. M. HESKETH (a2), G. KAFATOS (a3), J. V. PARRY (a4) (a5) and M. E. RAMSAY (a1)
  • DOI: http://dx.doi.org/10.1017/S0950268809002143
  • Published online: 10 March 2009
Abstract
SUMMARY

Hepatitis C is a global health problem and in the UK seroprevalence studies have mainly concentrated on specific high-risk groups. The aim of this study was to determine changes in the prevalence of antibody to hepatitis C virus in England using residual specimens collected between 1986 and 2000 reflecting the general population. A cross-sectional study design using a convenience collection of serum specimens from adult patients submitted to laboratories in the years 1986, 1991, 1996 and 2000 from a total of 19 laboratories around England were investigated. The main outcome was to determine anti-HCV prevalence and the average incidence occurring between 1986 and 2000 and factors associated with infection. Multivariable analysis of results from all years showed there was a significant difference in prevalence between males and females (P<0·001), birth cohort (P<0·001) and by health region (P<0·001). An average of 0·72% (95% CI 0–1·65%) of those susceptible to HCV born between 1950 and 1970 were estimated to have acquired the infection between 1986 and 2000. Analysis of this convenience serum collection suggests that HCV prevalence is low in the general population, and is associated with period of birth, gender and health region. There was evidence to support a low incidence of HCV infection in those born between 1950 and 1970 over the period 1986–2000 which, at the population level, equated to a substantial burden of infection (~106 000 persons). Continued surveillance and prevention targeted at injecting drug users are essential for the control of hepatitis C in the UK.

Copyright
Corresponding author
*Author for correspondence: Dr M. A. Balogun, Health Protection Agency, Centre for Infections, Immunisation Department, 61 Colindale Avenue, LondonNW9 5EQ, UK. (Email: koye.balogun@hpa.org.uk)
Linked references
Hide All

This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.

2.A Majid , Molecular epidemiology of hepatitis C virus infection amongst intravenous drug users in rural communities. Journal of Medical Virology 1995; 46: 4851.

6.K Soldan , JAJ Barbara , J Heptonstall . Incidence of seroconversion to positivity for hepatitis C antibody in repeat blood donors in England, 1993–5. British Medical Journal 1998; 316: 14131417.

7.MA Balogun , The prevalence and genetic diversity of hepatitis C infection in antenatal clinic attenders in two regions of England. Epidemiology and Infection 2000; 125: 705712.

8.G Ward , Prevalence of hepatitis C among pregnant women attending an inner London obstetric department: uptake and acceptability of named antenatal testing. Gut 2000; 47: 277280.

9.D Goldberg , Hepatitis C virus among high and low risk pregnant women in Dundee: unlinked anonymous testing. British Journal of Obstetrics and Gynaecology 2001; 108: 365370.

10.TG Wreghitt , Transmission of hepatitis C virus by organ transplantation in the United Kingdom. Journal of Hepatology 1994; 20: 768772.

11.J Zuckerman , Prevalence of hepatitis C antibodies in clinical health care workers. Lancet 1994; 343: 16181620.

13.MA Balogun , The prevalence of hepatitis C in England and Wales. Journal of Infection 2002; 45: 119226.

14.K Osborne , Ten years of serological surveillance in England and Wales: methods, results, implications and action. International Journal of Epidemiology 2000; 29: 362368.

17.A Nardone , Seroepidemiology of Bordetella pertussis in England and Wales. Vaccine 2004; 22: 13141319.

19.PAC Maple , Immunity to diphtheria and tetanus in England and Wales. Vaccine 2001; 19: 167173.

22.H Kelly , A random cluster survey and a convenience sample give comparable estimates of immunity to vaccine preventable diseases in children of school age in Victoria, Australia. Vaccine 2002; 20: 31303136.

23.U Gungabissoon , MA Balogun , ME Ramsay . Hepatitis C virus: laboratory surveillance in England and Wales, 1992–2004. Epidemiology and Infection 2007; 135: 541548.

24.MA Balogun , A national survey of genitourinary medicine clinic attenders provides little evidence of sexual transmission of hepatitis C virus infection. Sexually Transmitted Infections 2003; 79: 301306.

27.AJ Sutton , Modelling the characteristics of the male injecting drug user population in England and Wales. International Journal of Drug Policy 2005; 16: 176182.

28.M Sweeting , The burden of hepatitis C in England. Journal of Viral Hepatitis 2007; 14: 570576.

29.G Hughes , I Simms , G Leong . Data from UK genitourinary medicine clinics, 2006: a mixed picture. Sexually Transmitted Infections 2007; 83: 433435.

Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Epidemiology & Infection
  • ISSN: 0950-2688
  • EISSN: 1469-4409
  • URL: /core/journals/epidemiology-and-infection
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Keywords: